The move is an attempt from the privately held Merz to increase its footprint in the aesthetics field as BioForm Medical currently manufactures a number of dermal filler products marketed under the brand name Radiesse.

“We are pleased with this transaction, which has been strongly supported by Merz shareholders. Together with BioForm Medical, we will have even greater potential for future growth in our worldwide, fast growing aesthetics and dermatological business,” said Dr. Jochen Huckmann, Chairman of the Merz Shareholders Council.

Merz will be paying approximately $253m (€176.2m) for the California-based company.